Enamine

Website: http://www.enamine.net
Enamine was founded in 1991 with the advent of high throughput screening in early drug discovery. The driving force of the company’s development was the rapidly increasing demand for new chemical compounds. Over the past 20 years, Enamine has become a global provider of Screening Compounds, Building Blocks, and Fragments for supporting a wide range of research programs conducted by pharmaceutical and biotech companies, drug discovery centres, academic institutions and other research organizations worldwide.
Over the years, the company has developed a comprehensive set of R&D services to meet the ever increasing needs of the customers. Enamine supports complex medicinal chemistry programs offering the following chemical services: custom synthesis, compound library design, hit follow up support, support for lead optimization.
The Enamine headquarters occupy the space of 5 acres in Kyiv, Ukraine with multiple buildings for chemical and analytical labs, compound stock facilities, operations and business departments. It also has several stock facilities in the USA and Europe and it works through authorized representatives in Asian region.